Additional identifiers
EudraCT/CTIS number
IRAS number
ClinicalTrials.gov number
Protocol/serial number
PSI A-88
Study information
Scientific title
Acronym
Study hypothesis
Service level agreements (SLAs) are a means of improving communication and collaboration between primary and secondary care. They reflect local needs and resources and specify the services to be provided, including guidelines for communication, referral and shared care. This study will use a randomised controlled trial to examine the effect of locally negotiated SLAs on the health and quality of care of the long term mentally ill.
Ethics approval(s)
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Study setting(s)
Not specified
Study type
Not Specified
Patient information sheet
Condition
Mental and behavioural disorders: Schizophrenia and other psychoses
Intervention
1. Locally negotiated service level agreements
2. Standard care
Intervention type
Other
Primary outcome measure
The principal outcome measures will include levels of disability, mental ill health, self care and quality of life. Global Assessment of Functioning (GAF), Health of the Nation Outcome Scale (HoNOS), Verona Satisfaction Scales (VECS and VSSS), GHQ for patient carers, Client Service Receipt Interview (CSRI) to assess cost, questionnaires to evaluate staff views on the clarity of roles and attitudes to the primary/secondary care interface.
Secondary outcome measures
Not provided at time of registration
Overall study start date
01/02/1997
Overall study end date
01/10/2000
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Practices: General practices with a majority of their patients within the Mental Health Trust boundaries, with a computerised repeat prescribing system.
Patients: Patients with long term mental illness based on the criteria of duration, diagnosis and disability. Patients with diagnoses of schizophrenia and related disorders and bipolar affective disorder will be included, in addition to those with chronic relapsing depression or on prophylactic antidepressants for more than six months. Those disabled by chronic neurotic disorders will also be included.
Participant type(s)
Patient
Age group
Not Specified
Sex
Not Specified
Target number of participants
Not provided at time of registration
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/02/1997
Recruitment end date
01/10/2000
Locations
Countries of recruitment
England, United Kingdom
Study participating centre
Department of General Practice
London
SE11 6SP
United Kingdom
Sponsor information
Organisation
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Sponsor details
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Sponsor type
Government
Website
Funders
Funder type
Government
Funder name
NHS Primary and Secondary Care Interface National Research and Development Programme (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Individual participant data (IPD) sharing plan
IPD sharing plan summary
Not provided at time of registration
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/04/2004 | Yes | No |